The WHO Updated Diagnostic Criteria for ET, PV & MF

Earn CME for related activities: https://www.naccme.com/oln

In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA, Dr. Mark Heaney discusses the updated WHO diagnostic criteria for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).

© 2016 Imedex, LLC.